直接口服抗凝剂在膜疾病和假体门:为什么不?
Konstantinos Lampropoulos1,2, Michail Penteris3, Grigorios Gerotziafas4,5
1School of Medicine, European University of Cyprus, Nicosia, Cyprus.
Cardiovascular drugs and therapy
|June 20, 2025
概括
直接口服抗凝剂 (DOACs) 与维生素K对抗剂 (VKAs) 具有类似的疗效和安全性,用于心脏膜疾病 (VHD) 的心房动 (AF). 然而,由于DOAC试验数据有限,VKA仍然是特定高风险VHD患者的首选.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 血栓形成的原因之一是血栓形成.
背景情况:
- 心脏病 (VHD) 和心房动 (AF) 经常同时存在,产生需要抗凝血的前血栓状况.
- 维生素K对抗剂 (VKA) 是标准的,但直接口服抗凝剂 (DOAC) 代表了治疗的进步.
研究的目的:
- 评估在AF和VHD患者中DOAC与VKA的作用和比较结果.
- 确定特定的VHD子组,其中DOAC可能是可行的或VKA仍然需要的.
主要方法:
- 对临床试验数据的综述,比较不同类型VHD的AF患者的DOAC和VKA.
- 对安全性和疗效结果的分析,包括血栓栓塞和出血事件.
- 考虑指导方针和专家建议,如EHRA分类.
主要成果:
- 在一般AF和VHD人群中,DOAC显示了与VKA相比的可比有效性和更好的安全性.
- 支持DOACs的可靠数据缺乏严重的额头肌狭窄症,机械门和风湿性心脏病,其中VKAs是首选的.
- 在等待个性化风险评估之前,DOAC可能适用于生物假体门或TAVI后患者.
结论:
- 对于许多患有AF和VHD的患者来说,DOAC为VKA提供了方便和有效的替代方案.
- 由于DOACs的证据不足,VKA仍然是特定高风险VHD人群选择的抗凝剂.
- 在这个复杂的患者群体中,个性化风险益处评估和患者特异性因素对于优化抗凝治疗至关重要.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
924
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
924
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
655
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
655
Mitral Stenosis III: Medical Management
29
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
29
Heart Valves
5.9K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
5.9K


